Alper DUNKI
Bone Grafts, BMP, and Bone Substitutes
Purpose: Enhance fracture healing, treat nonunion, arthrodesis, fill bone defects
Mechanisms:
Osteogenesis → viable bone-forming cells
Osteoinduction → growth factors (e.g., BMP)
Osteoconduction → scaffold for bone growthGold Standard: Autograft (provides all three mechanisms)
Alternatives: Allograft, DBM, ceramics (HA, β-TCP), collagen, bone marrow aspirate
BMPs: rhBMP-2 & rhBMP-7 → used in spinal fusion, long bone nonunion
Limitations: Risk of ectopic bone, swelling, variable efficacy, cost issues
Adjuncts: Electromagnetic stimulation, low-intensity ultrasound (experimental)
Bone Healing
Primary healing
Occurs with fixation that provides absolute stability.
In open reduction and internal fixation, disruption of the fracture hematoma may delay early healing.
Direct healing occurs through cortical remodeling.
Areas lacking direct contact are initially filled with woven bone, which later remodels into lamellar bone.
Secondary healing
Takes place in the periosteum and surrounding soft tissues.
Both endochondral and intramembranous ossification may occur simultaneously.
Phases of bone healing
Inflammation: Hematoma formation, migration of inflammatory cells, angiogenesis, BMP-mediated mesenchymal stem cell differentiation.
Reparative phase: Formation of woven bone (soft callus), osteoid seam, cartilaginous bridge, and calcification.
Remodeling phase: Resorption and formation occur concurrently; Wolff’s law is the guiding principle.
Factors impairing healing:Excessive instability, poor vascularity, periosteal damage, use of NSAIDs/corticosteroids, smoking, systemic metabolic bone disease.
2. Role of Bone Grafts
Indications: Fracture healing, delayed union/nonunion, arthrodesis, repair of bone defects.
Physiologic mechanisms:
Osteogenesis: Provides viable bone-forming cells (e.g., autograft, bone marrow aspirate).
Osteoinduction: Provides factors stimulating cell differentiation (e.g., BMP).
Osteoconduction: Provides a scaffold for new bone formation (e.g., cancellous bone).
3. Bone Graft Materials
Autograft
Harvested from the same individual; considered the gold standard with osteogenic, osteoinductive, and osteoconductive properties.
Types: Cortical (high structural support, low cellular/factor content), cancellous (low structural support, high cellular/factor content), corticocancellous.
Iliac crest graft is most common; complications include pain, hematoma, nerve injury, infection, fracture.
Local autograft (e.g., lamina after laminectomy) is limited in quantity.
Allograft
Harvested from cadavers; weak osteogenic potential; sterilization reduces osteoinductivity.
Types: Fresh (rarely used), frozen, freeze-dried, demineralized bone matrix (DBM).
DBM: Mineral removed, collagen structure preserved; osteoinductive potential varies with processing, provides no structural support.
Autologous bone marrow aspirate
Source of mesenchymal stem cells; used alone or combined with grafts.
Collagen
Supports mineralization and vascularization; does not provide structural support; often used as a carrier.
Inorganic compounds and bioceramics
HA, β-TCP, bioactive glass; compressive strength, osteoconductive; resorption rates differ.
4. Bone Morphogenetic Proteins (BMP)
Members of the TGF-β superfamily; only certain types are osteoinductive (e.g., BMP-2, BMP-7).
Recombinant forms: rhBMP-2 (used in spinal fusion, tibial fractures), rhBMP-7 (used in long bone nonunions).
Efficacy: Comparable clinical outcomes to ICBG; some studies report higher radiological fusion rates.
Complications: Ectopic bone formation, regional swelling, increased complication rates with some fusion techniques.
5. Combined Graft Use
Different grafts may be combined to complement properties or compensate for insufficient volume (e.g., cortical allograft + DBM + local bone).
6. Other Methods to Enhance Bone Healing
Electromagnetic stimulation: Based on alteration of bioelectric potentials at the healing site; clinical efficacy is variable.
Types: Pulsed electromagnetic field, capacitive coupling, direct current stimulation.
Low-intensity ultrasound: Potentially beneficial; not widely used in clinical practice.
References
1. Zhang, J., Wang, Y., & Jin, D. (2025). Research progress of bone grafting: A comprehensive review. International Journal of Nanomedicine,
2. Von Benecke, J. P., & ark. (2024). A narrative review on recombinant human bone morphogenetic protein-2: Where are we now? Cureus, Article e.g. 2024.
